About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDPhase 2NCT00702156

Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease

The principal research objectives are to demonstrate cardioselective beta-blockade using bisoprolol is not inferior to placebo with regard to pulmonary function and improves quality of life in patient...

Lead sponsor: NHS Greater Glasgow and Clyde•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

NHS Greater Glasgow and Clyde

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•symptomatic NYHA II or III chronic heart failure
•left ventricular systolic dysfunction
•moderate or severe chronic obstructive pulmonary disease
•with or without significant reversibility

Exclusion Criteria

•beta-blocker contraindications
•non-dihydropyridine (diltiazem / verapamil) calcium channel blockers
•recent coronary percutaneous intervention or coronary artery bypass graft surgery
•haemodynamically significant valvular disease or hypertrophic cardiomyopathy.
•active myocarditis or pericarditis.
•recent cerebrovascular accident or transient ischaemic attack
•serious concurrent systemic disease, such as malignancy, resulting in likely reduced life expectancy
•pregnancy, childbearing potential with inadequate contraception, breast feeding

Related studies

RECRUITINGPhase 2

A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

NCT07083011 · Heart Failure With Preserved Ejection Fraction

RECRUITINGPhase 3

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

NCT07037459 · Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, and more

Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure

NCT07550790 · Heart Failure Acute, Renal Dysfunction

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

RECRUITINGPhase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

NCT07190209 · Chronic Obstructive Pulmonary Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 3, 2008Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment27

Start dateMar 2005

Last updatedSep 3, 2008

Condition

Heart Failure Chronic Obstructive Pulmonary Disease

Locations shown

Cardiopulmonary Transplant Unit Glasgow Royal Infirmary

Glasgow, Scotland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 3, 2008Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions